Home / Expertise / Life Sciences & Healthcare
Lifesciences & Healthcare

Life Sciences & Healthcare

Colombia

Globally, CMS is an international leader in the Lifesciences & Health Care Sector, with over 150 specialized lawyers and 100 Lifesciences companies as clients, including the top 20 global pharmaceutical companies and nine out of top ten global medical device companies.

In CMS Rodríguez-Azuero we understand that the goal of your company is the successful and uneventful commercialization of their products; and we know well the obstacles and contingencies that could become obstacles towards such goal.

We advise our clients in matters related to Health Regulations (concerning market approvals, labelling, advertisement and composition restrictions), Intellectual Property (in regards to biotech patents, development of breakthrough products, licensing), compliance, consumer law, competition, drug and device safety, clinical trials, disputes, and merger and acquisitions projects.

Read more Read less

Feed

Show only
27 April 2020
Pro­ced­ures of San­it­ary Reg­u­la­tion for “Non-In­dis­pens­able” Products in times...
"Com­ments on the Health reg­u­la­tions situ­ation for products that are not used for crisis man­age­ment"
20 April 2020
CMS Ex­pert Guide to ad­vert­ising of medi­cines and med­ic­al devices
Are you look­ing for in­form­a­tion on phar­ma­ceut­ic­al ad­vert­ising reg­u­la­tion and med­ic­al device ad­vert­ising? Learn more about it in this CMS Ex­pert Guide.
13 April 2020
Colom­bi­a's Health Au­thor­ity ad­apts to COV­ID Health Emer­gency: On­line pro­ced­ures,...
20 April 2020
CMS Ex­pert Guide to can­nabis law and le­gis­la­tion
Are you look­ing for in­form­a­tion on can­nabis law and le­gis­la­tion? This CMS Ex­pert Guide provides you with everything you need to know.
08 July 2019
Policy of Pre­ven­tion of Anti-Ju­di­cial Dam­age and De­fense Of IN­VIMA In­terests
07 June 2019
Ar­ti­fi­cial In­tel­li­gence is the new Elec­tri­city
Dec 2018
CMS Life Sci­ences & Health­care Sec­tor Group: An over­view of our Asia-Pa­cific,...